Algirdas Grevys

1.0k citations

16 papers · 688 indexed · h-index 14

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research
Immunology
- T-cell and B-cell Immunology

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 13
- Monoclonal and Polyclonal Antibodies Research 13
Hematology 5
- Blood groups and transfusion 3
- Platelet Disorders and Treatments 2

Co-authors: Jan Terje Andersen (16 shared papers)Inger Sandlie (13 shared papers)Terje E. Michaelsen (6 shared papers)Jeannette Nilsen (7 shared papers)Malin Bern (7 shared papers)Kine Marita Knudsen Sand (7 shared papers)Stian Foss (9 shared papers)D. B. Bratlie (2 shared papers)
Journals: The Journal of Immunology (2 papers)Scientific Reports (2 papers)Communications Biology (2 papers)Journal of Controlled Release (2 papers)iScience (1 paper)
Partner nations: Norway United States United Kingdom

In The Last Decade

Algirdas Grevys

16 papers receiving 680 citations

Peers

Countries citing papers authored by Algirdas Grevys

Since Specialization

Citations

This map shows the geographic impact of Algirdas Grevys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Algirdas Grevys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Algirdas Grevys more than expected).

Fields of papers citing papers by Algirdas Grevys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Algirdas Grevys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Algirdas Grevys. The network helps show where Algirdas Grevys may publish in the future.

Co-authors

The 25 scholars most cited alongside Algirdas Grevys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Algirdas Grevys Line = papers co-authored together Algirdas Grevys links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies Nature Nanotechnology ·Alan Shaw, Ian T. Hoffecker, Ioanna Smyrlaki, João Rosa, Algirdas Grevys, D. B. Bratlie, Inger Sandlie, Terje E. Michaelsen, Jan Terje Andersen, Björn Högberg	2019	146
2	Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin Journal of Controlled Release ·Cláudia Azevedo, Jeannette Nilsen, Algirdas Grevys, Rute Nunes, Jan Terje Andersen, Bruno Sarmento	2020	68
3	A human endothelial cell-based recycling assay for screening of FcRn targeted molecules Nature Communications ·Algirdas Grevys, Jeannette Nilsen, Kine Marita Knudsen Sand, Muluneh Bekele Daba, Inger Øynebråten, Malin Bern, Martin B. McAdam, Stian Foss, Tilman Schlothauer, Terje E. Michaelsen, Gregory J. Christianson, Derry C. Roopenian, Richard S. Blumberg, Inger Sandlie, Jan Terje Andersen	2018	64
4	Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions The Journal of Immunology ·Algirdas Grevys, Malin Bern, Stian Foss, D. B. Bratlie, Anders Moen, Kristin Støen Gunnarsen, Audun Aase, Terje E. Michaelsen, Inger Sandlie, Jan Terje Andersen	2015	62
5	Human and mouse albumin bind their respective neonatal Fc receptors differently Scientific Reports ·Jeannette Nilsen, Malin Bern, Kine Marita Knudsen Sand, Algirdas Grevys, Bjørn Dalhus, Inger Sandlie, Jan Terje Andersen	2018	52
6	An intact C-terminal end of albumin is required for its long half-life in humans Communications Biology ·Jeannette Nilsen, Esben Trabjerg, Algirdas Grevys, Cláudia Azevedo, Stephen O. Brennan, Maria Stensland, John J. Wilson, Kine Marita Knudsen Sand, Malin Bern, Bjørn Dalhus, Derry C. Roopenian, Inger Sandlie, Kasper D. Rand, Jan Terje Andersen	2020	48
7	Interaction with Both Domain I and III of Albumin Is Required for Optimal pH-dependent Binding to the Neonatal Fc Receptor (FcRn) Journal of Biological Chemistry ·Kine Marita Knudsen Sand, Malin Bern, Jeannette Nilsen, Bjørn Dalhus, Kristin Støen Gunnarsen, Jason Cameron, Algirdas Grevys, Karen Bunting, Inger Sandlie, Jan Terje Andersen	2014	42
8	Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions Blood ·Line Mathiesen, Leif Kofoed Nielsen, Jan Terje Andersen, Algirdas Grevys, Inger Sandlie, Terje E. Michaelsen, Morten Hedegaard, Lisbeth E. Knudsen, Morten Hanefeld Dziegiel	2013	36
9	Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life iScience ·Algirdas Grevys, Rahel Frick, Simone Mester, Karine Flem‐Karlsen, Jeannette Nilsen, Stian Foss, Kine Marita Knudsen Sand, Thomas Emrich, Jens A. A. Fischer, Victor Greiff, Inger Sandlie, Tilman Schlothauer, Jan Terje Andersen	2022	35
10	TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity The Journal of Immunology ·Stian Foss, Ruth Watkinson, Algirdas Grevys, Martin B. McAdam, Malin Bern, Lene S. Høydahl, Bjørn Dalhus, Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	2016	34
11	FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity The Journal of Experimental Medicine ·Jonathan J. Hubbard, Michał Pyzik, Timo Räth, Lisa K. Kozicky, Kine Marita Knudsen Sand, Amit Gandhi, Algirdas Grevys, Stian Foss, Susan C. Menzies, Jonathan N. Glickman, Edda Fiebiger, Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen, Laura M. Sly, Kristi Baker, Richard S. Blumberg	2020	34
12	Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties Scientific Reports ·Magne Sand Sivertsen, Øystein Kalsnes Jørstad, Algirdas Grevys, Stian Foss, Morten C. Moe, Jan Terje Andersen	2018	24
13	Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization Journal of Controlled Release ·Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Patricia A. Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie, Jan Terje Andersen	2015	23
14	Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life Communications Biology ·Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Lene S. Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe, Jan Terje Andersen	2022	14
15	Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life PNAS Nexus ·Simone Mester, Chilam Chan, Marta Lustig, Stian Foss, J.H. Marco Jansen, Marie Leangen Herigstad, Mitchell Evers, Jeannette Nilsen, Karli R. Reiding, J Damen, Renate Burger, Algirdas Grevys, Bjørn Dalhus, Thomas Valerius, Inger Sandlie, Jeanette H.W. Leusen, Jan Terje Andersen	2025	3
16	NHDL, a recombinant V _L /V _H hybrid antibody control for IgG2/4 antibodies mAbs ·Corinna Lau, Martin B. McAdam, Grethe Bergseth, Algirdas Grevys, Jack‐Ansgar Bruun, Judith Krey Ludviksen, Hilde Fure, Terje Espevik, Anders Moen, Jan Terje Andersen, Tom Eirik Mollnes	2019	3

About Algirdas Grevys

Algirdas Grevys is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology, Immunology, Molecular Biology and Pharmaceutical Science, having authored 16 papers that have together received 688 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (6 papers), Protein purification and stability (5 papers), Blood groups and transfusion (3 papers), Protein Interaction Studies and Fluorescence Analysis (3 papers), Platelet Disorders and Treatments (2 papers), Hemoglobin structure and function (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (324 citations), Immunology (181 citations), Pharmaceutical Science (45 citations), Hematology (69 citations) and Molecular Biology (412 citations). Algirdas Grevys has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Jan Terje Andersen, Inger Sandlie, Terje E. Michaelsen, Jeannette Nilsen, Malin Bern, Kine Marita Knudsen Sand, Stian Foss, D. B. Bratlie, Bjørn Dalhus and Björn Högberg. Their work appears in journals such as The Journal of Immunology, Scientific Reports, Communications Biology, Journal of Controlled Release and iScience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact